Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program

被引:219
作者
Ernster, VL
Barclay, J
Kerlikowske, K
Wilkie, H
Ballard-Barbash, R
机构
[1] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[2] Dept Vet Affairs, Gen Internal Med Sect, San Francisco, CA USA
[3] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
关键词
D O I
10.1001/archinte.160.7.953
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Over 14% of breast cancers diagnosed in the United States annually are ductal carcinomas in situ (DCIS). There are no published population-based reports of the likelihood of breast cancer death among US women with DCIS. Methods: We used data from the Surveillance, Epidemiology and End Results program to determine the likelihood of breast cancer death at 5 and 10 years among US women aged 40 and older diagnosed with DCIS from 1978 to 1983 (before screening mammography was common; n = 1525) and from 1984 to 1989 (when screening mammography became common; n = 5547). We also calculated standardized mortality ratios (SMRs) to compare observed deaths from breast cancer, cardiovascular disease, and all causes combined among women with DCIS with deaths expected based on general population mortality rates. Results: Among women diagnosed with DCIS from 1978 to 1983, 1.5% died of breast cancer within 5 years and 3.4% within 10 years. Among women diagnosed from 1984 to 1989, 0.7% died of breast cancer within 5 years and 1.9% within 10 years. Relative to the general population, risk of breast cancer death was greater for women diagnosed from 1978 to 1983 (SMR, 3.4; 95% confidence interval [CI], 2.5-4.5) than for women diagnosed from 1984 to 1989 (10-year SMR, 1.9; 95% CI, 1.5-2.3). Women diagnosed from 1984 to 1989 were significantly less likely than women in the general population to have died of cardiovascular diseases (10-year SMR, 0.6; 95% CI, 0.5-0.7) or of all causes combined (SMR, 0.8; 95% CI, 0.7-0.8). Conclusions: Among women diagnosed with DCIS, risk of death from breast cancer was low, at least within the 10 years following diagnosis. This may reflect the effectiveness of treatment for DCIS, the "benign" nature of DCIS, or both. At 10 years, women diagnosed from 1984 to 1989 were less likely than women diagnosed from 1978 to 1983 to have died of breast cancer, and their risk of dying of all causes combined was lower than that in the general population.
引用
收藏
页码:953 / 958
页数:6
相关论文
共 27 条
  • [1] ESTROGEN AND CORONARY HEART-DISEASE IN WOMEN
    BARRETTCONNOR, E
    BUSH, TL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (14): : 1861 - 1867
  • [2] POSTMENOPAUSAL ESTROGEN AND PREVENTION BIAS
    BARRETTCONNOR, E
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 455 - 456
  • [3] Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
  • [4] Breslow NE, 1980, STAT METHODS CANC RE, V1, DOI DOI 10.1097/00002030-199912240-00009
  • [5] CANNER PL, 1980, NEW ENGL J MED, V303, P1038
  • [6] Bone mineral density and risk of breast cancer in older women - The study of osteoporotic fractures
    Cauley, JA
    Lucas, FL
    Kuller, LH
    Vogt, MT
    Browner, WS
    Cummings, SR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (17): : 1404 - 1408
  • [7] Incidence of and treatment for ductal carcinoma in situ of the breast
    Ernster, VL
    Barclay, J
    Kerlikowske, K
    Grady, D
    Henderson, IC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (12): : 913 - 918
  • [8] ERNSTER VL, 1997, DUCTAL CARCINOMA IN, P23
  • [9] Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
    Fisher, B
    Dignam, J
    Wolmark, N
    Wickerham, DL
    Fisher, ER
    Mamounas, E
    Smith, R
    Begovic, M
    Dimitrov, NV
    Margolese, RG
    Kardinal, CG
    Kavanah, MT
    Fehrenbacher, L
    Oishi, RH
    [J]. LANCET, 1999, 353 (9169) : 1993 - 2000
  • [10] Postmenopausal hormone therapy and mortality
    Grodstein, F
    Stampfer, MJ
    Colditz, GA
    Willett, WC
    Manson, JE
    Joffe, M
    Rosner, B
    Fuchs, C
    Hankinson, SE
    Hunter, DJ
    Hennekens, CH
    Speizer, FE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (25) : 1769 - 1775